Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Dallas, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Phoenix, AZ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Orange, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Orange, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
San Francisco, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Tallahassee, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Park Ridge, IL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Hackensack, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Cincinnati, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Hilliard, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Hilliard, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Galveston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Galveston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Newark, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
La Rioja,
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
La Rioja,
Click here to add this to my saved trials
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Status: Enrolling
Updated:  12/31/1969
Alliance for Clinical Trials in Oncology
mi
from
Boston, MA
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
Status: Enrolling
Updated: 12/31/1969
Alliance for Clinical Trials in Oncology
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Chapel Hill, NC
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Winston-Salem, NC
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Lake Worth, FL
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Idaho Falls, ID
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Los Angeles, CA
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
Norfolk, VA
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated:  12/31/1969
Research Center
mi
from
South Brisbane,
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Status: Enrolling
Updated: 12/31/1969
Research Center
mi
from
South Brisbane,
Click here to add this to my saved trials
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
Status: Enrolling
Updated:  12/31/1969
Teton Cancer Institute
mi
from
Idaho Falls, ID
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
Status: Enrolling
Updated: 12/31/1969
Teton Cancer Institute
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
A Phase I/II Clinical Trial of pNGVL4a-Sig/E7 (Detox)/HSP70 for the Treatment of Patients With HPV 16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
A Phase I/II Clinical Trial of pNGVL4a-Sig/E7 (Detox)/HSP70 for the Treatment of Patients With HPV 16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects
Status: Enrolling
Updated:  12/31/1969
Tampa Bay Uveitis Center
mi
from
Saint Petersburg, FL
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects
Status: Enrolling
Updated: 12/31/1969
Tampa Bay Uveitis Center
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Physical Activities by Technology Help (PATH)
Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Physical Activities by Technology Help (PATH)
Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
An Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Vilaprisan in Subjects With Decreased Renal Function in Comparison With Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer
Caloric Restriction for Oncology Research: Pre-operative Caloric Restriction Prior to Definitive Oncologic Surgery
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer
Caloric Restriction for Oncology Research: Pre-operative Caloric Restriction Prior to Definitive Oncologic Surgery
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Radnet Management
mi
from
Los Angeles, CA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Radnet Management
mi
from
Los Angeles, CA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
University MRI
mi
from
Boca Raton, FL
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
University MRI
mi
from
Boca Raton, FL
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
mi
from
Burlington, MA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
Virtua
mi
from
Voorhees, NJ
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
Virtua
mi
from
Voorhees, NJ
Click here to add this to my saved trials
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated:  12/31/1969
North Texas Uterine Fibroid Institute
mi
from
Plano, TX
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Status: Enrolling
Updated: 12/31/1969
North Texas Uterine Fibroid Institute
mi
from
Plano, TX
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
mi
from
Burlington, MA
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
KNI
mi
from
Kalamazoo, MI
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
KNI
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Cornell Vascular
mi
from
New York, NY
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Cornell Vascular
mi
from
New York, NY
Click here to add this to my saved trials
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated:  12/31/1969
Toronto General Hospital
mi
from
Toronto,
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques
Status: Enrolling
Updated: 12/31/1969
Toronto General Hospital
mi
from
Toronto,
Click here to add this to my saved trials